Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

AMC Gains as Venom, James Bond’s No Time to Die Set New Records

Published 10/04/2021, 09:19 AM
Updated 10/04/2021, 09:20 AM
© Reuters

© Reuters

By Dhirendra Tripathi

Investing.com – AMC stock (NYSE:AMC) rose 1.5% on Monday in premarket trading following a record opening weekend collection by Venom: Let There Be Carnage and the latest Bond flick, No Time To Die.

The multiplex operator said it has new post-reopening records for global attendance, admission revenue and food and beverage sales for a single weekend.

Sony’s Let There Be Carnage grossed an estimated $90 million in ticket sales, the second-biggest ever domestic opening of an October movie in cinema history.

The 25th James Bond movie shattered ticket sales records across the Atlantic. Including Saturday, one-day ticket admission revenue in the U.K. was the highest for any Bond movie ever since the franchise was launched back in 1962.

AMC said more than 2.4 million moviegoers watched a movie at its U.S. theatres Thursday through Sunday.

The approximately 3.9 million attendance, Thursday through Sunday, at all AMC Entertainment locations globally is a new post-reopening weekend high, the company said.

No Time To Die will open in the U.S. on October 8 while Let There Be Carnage will open in Europe on October 15.

 

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.